SUNNISIDE HEALTHCARE LIMITEDActive

Company number 07593597Private limited companyIncorporated 2011

Key figures

£662,980+0.5%
Net assets 2024/25
+2.5%
Average annual growth 2019/20–2024/25
0200 k400 k600 k800 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, SUNNISIDE HEALTHCARE LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0500 k1 m2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand48,80653,04521,8343,94433,261
Total assets860,654849,459829,875842,443836,228
Total liabilities218,501167,193180,624181,805172,501
Net assets / total equity651,388682,266648,009659,619662,980
Average number of employees11111100

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: SUNNISIDE HEALTHCARE LIMITED

Company

SUNNISIDE HEALTHCARE LIMITED is a private limited company registered with Companies House under company number 07593597. It was incorporated on 6 Apr 2011. Its status is active. The registered office is in Newcastle upon tyne (NE16). Its nature of business (SIC 2007) is wholesale of pharmaceutical goods (46460).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Jul 2025); the company files small company accounts (filleted). Net assets were £662,980, up 0.5% on the previous year. Cash at bank and in hand was £33,261. Total assets were £836,228 and total liabilities £172,501. The company had an average of 0 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered. 1 of 3 registered charges are outstanding.

Filing deadlines

The next accounts are due by 30 Apr 2027. The next confirmation statement is due by 18 Apr 2027.